COHEN YUVAL (Chief Executive Officer) sold 7.4% of their position (13.87K shares) of CORBUS PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market sale worth $108.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2026ACC: 0001193125-26-057159
DirectorOfficer· Chief Executive Officer
Since Jan 2019
-13.87K
Net shares
Net seller
$108.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.87K disposed
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
−13.87K
Price / share
$7.78
Trade value
$107.95K
% of position
7.4%
2/13/2026
188.19K→174.32K
Total
Net shares
−13.87K
Net value
-$107.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 2/13/2026 | S · Sale | −13.87K | $7.78 | $107.95K | 7.4% | 188.19K | 174.32K |
| Total | −13.87K | -$107.95K | ||||||
Derivative Transactions0
No derivative transactions reported